NICE backs drugs over surgery for angina

Patients with stable angina should be first offered drug therapy before surgery is considered, according to a clinical guideline published by NICE.

The guideline recommends patients are offered one or two anti-anginal drugs as necessary, plus drugs for secondary prevention of cardiovascular disease.

Where stable angina is not controlled by these drugs, clinicians should consider revascularisation by a coronary artery bypass graft or percutaneous coronary intervention.

Northamptonshire GP Dr Jonathan Shribman, a GPSI in cardiology who helped develop the guideline, said: ‘This guideline clarifies the evidence-based management for stable angina and makes very clear who should be offered revascularisation and who should not.’

NICE clinical and public health director Professor Peter Littlejohns said the guideline will ‘improve patient care by allowing clinicians and their patients to make an informed decision in individual circumstances’.

An estimated two million people in England have or have had stable angina.

Click here for an in-depth look at the new guideline by Dr Shibman and Rotherham GP Dr Leonard Jacob, a GPSI in cardiology and cardiovascular disease.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Surrey GP practice targeted by aggressive anti-vaccination poster

Surrey GP practice targeted by aggressive anti-vaccination poster

Staff at a GP surgery in Surrey have been left completely demoralised after they...

JCVI issues final guidance on phase 2 of COVID-19 vaccination programme

JCVI issues final guidance on phase 2 of COVID-19 vaccination programme

The JCVI has confirmed the next phase of the COVID-19 vaccination programme will...

'Case-by-case' approach to GPs prescribing budesonide for COVID-19

'Case-by-case' approach to GPs prescribing budesonide for COVID-19

Inhaled budesonide is not expected to be routinely prescribed for patients receiving...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Over 45s offered COVID-19 jab as NHS completes vaccine offer to 32m priority patients

Over 45s offered COVID-19 jab as NHS completes vaccine offer to 32m priority patients

COVID-19 vaccination has been extended to patients aged 45-49 after the government...